Industry: Medical Devices & Consumables
Published Date: 2025-11-02
Pages: 225 Pages
Report ld: 4798596
Request Sample
Customized Report
PTCA Dilatation Balloon Catheters Market Size(US$)

CAGR 2025-2031
8.9%
Market Size,2031
USD 2,329
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global PTCA Dilatation Balloon Catheters market is projected to grow from US$ 1312 million in 2024 to US$ 2329 million by 2031, at a CAGR of 8.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
PTCA dilatation balloon catheters are interventional medical devices used in the treatment of coronary artery stenosis, primarily during percutaneous coronary intervention (PCI) procedures. These catheters work by inflating a balloon at the lesion site to dilate the narrowed vessel and restore blood flow, often serving as preparation for stent implantation. Designed with a focus on compliance, flexibility, and inflation stability, they are widely applied in both pre-dilation and post-dilation phases. Based on their compliance characteristics, PTCA balloon catheters are classified into semi-compliant and non-compliant types to meet a variety of clinical needs.
Currently, PTCA dilatation balloon catheters are widely used in the global cardiovascular interventional field and serve as essential consumables in percutaneous coronary intervention (PCI) procedures. The market is dominated by major international medical device manufacturers, whose products are continually evolving in terms of compliance, folding technology, pushability, and radiopacity to meet the demands of complex lesions and precise vessel expansion. In recent years, as cardiovascular disease rates continue to rise and interventional healthcare infrastructure improves in developing countries, the global usage of PTCA balloon catheters has steadily increased, with expanding clinical application and a growing market footprint.
Looking forward, the trend toward minimally invasive and personalized medicine will drive further innovation in PTCA catheter design, focusing on lower profiles, higher pressure capabilities, and improved trackability to enhance procedural accuracy and address more challenging anatomies. Emerging innovations such as imaging-guided technology, drug-coated balloon integration, high-compliance materials, and controlled inflation features are expected to become key areas for product differentiation. In regions like Asia-Pacific, Latin America, and the Middle East, market penetration is projected to rise rapidly, supported by infrastructure development and a growing base of interventional cardiologists.
However, the market also faces several challenges. On one hand, the industry is experiencing increasing product homogenization and price competition, particularly under centralized procurement policies in certain regions, which compress profit margins. On the other hand, rising raw material costs, stricter regulatory oversight, and increasingly complex clinical approval processes for advanced devices are putting pressure on both R&D and compliance. Additionally, significant disparities in technical standards and registration requirements across countries are slowing the global expansion efforts of smaller and emerging manufacturers.
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global PTCA Dilatation Balloon Catheters market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the PTCA Dilatation Balloon Catheters study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to PTCA Dilatation Balloon Catheters: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global PTCA Dilatation Balloon Catheters Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Semi-Compliant Type
1.2.3 Non-Compliant Type
1.3 Market Segmentation by Application
1.3.1 Global PTCA Dilatation Balloon Catheters Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global PTCA Dilatation Balloon Catheters Revenue Estimates and Forecasts 2020-2031
2.2 Global PTCA Dilatation Balloon Catheters Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global PTCA Dilatation Balloon Catheters Sales Estimates and Forecasts 2020-2031
2.4 Global PTCA Dilatation Balloon Catheters Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global PTCA Dilatation Balloon Catheters Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global PTCA Dilatation Balloon Catheters Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Semi-Compliant Type Market Size by Manufacturers
3.5.2 Non-Compliant Type Market Size by Manufacturers
3.6 Global PTCA Dilatation Balloon Catheters Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global PTCA Dilatation Balloon Catheters Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global PTCA Dilatation Balloon Catheters Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global PTCA Dilatation Balloon Catheters Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global PTCA Dilatation Balloon Catheters Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America PTCA Dilatation Balloon Catheters Sales and Revenue by Type (2020-2031)
6.4 North America PTCA Dilatation Balloon Catheters Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America PTCA Dilatation Balloon Catheters Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe PTCA Dilatation Balloon Catheters Sales and Revenue by Type (2020-2031)
7.4 Europe PTCA Dilatation Balloon Catheters Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe PTCA Dilatation Balloon Catheters Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific PTCA Dilatation Balloon Catheters Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific PTCA Dilatation Balloon Catheters Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific PTCA Dilatation Balloon Catheters Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America PTCA Dilatation Balloon Catheters Sales and Revenue by Type (2020-2031)
9.4 Central and South America PTCA Dilatation Balloon Catheters Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America PTCA Dilatation Balloon Catheters Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa PTCA Dilatation Balloon Catheters Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa PTCA Dilatation Balloon Catheters Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa PTCA Dilatation Balloon Catheters Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Boston Scientific
11.1.1 Boston Scientific Corporation Information
11.1.2 Boston Scientific Business Overview
11.1.3 Boston Scientific PTCA Dilatation Balloon Catheters Product Models, Descriptions and Specifications
11.1.4 Boston Scientific PTCA Dilatation Balloon Catheters Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Boston Scientific PTCA Dilatation Balloon Catheters Sales by Product in 2024
11.1.6 Boston Scientific PTCA Dilatation Balloon Catheters Sales by Application in 2024
11.1.7 Boston Scientific PTCA Dilatation Balloon Catheters Sales by Geographic Area in 2024
11.1.8 Boston Scientific PTCA Dilatation Balloon Catheters SWOT Analysis
11.1.9 Boston Scientific Recent Developments
11.2 Abbott
11.2.1 Abbott Corporation Information
11.2.2 Abbott Business Overview
11.2.3 Abbott PTCA Dilatation Balloon Catheters Product Models, Descriptions and Specifications
11.2.4 Abbott PTCA Dilatation Balloon Catheters Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Abbott PTCA Dilatation Balloon Catheters Sales by Product in 2024
11.2.6 Abbott PTCA Dilatation Balloon Catheters Sales by Application in 2024
11.2.7 Abbott PTCA Dilatation Balloon Catheters Sales by Geographic Area in 2024
11.2.8 Abbott PTCA Dilatation Balloon Catheters SWOT Analysis
11.2.9 Abbott Recent Developments
11.3 Medtronic
11.3.1 Medtronic Corporation Information
11.3.2 Medtronic Business Overview
11.3.3 Medtronic PTCA Dilatation Balloon Catheters Product Models, Descriptions and Specifications
11.3.4 Medtronic PTCA Dilatation Balloon Catheters Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Medtronic PTCA Dilatation Balloon Catheters Sales by Product in 2024
11.3.6 Medtronic PTCA Dilatation Balloon Catheters Sales by Application in 2024
11.3.7 Medtronic PTCA Dilatation Balloon Catheters Sales by Geographic Area in 2024
11.3.8 Medtronic PTCA Dilatation Balloon Catheters SWOT Analysis
11.3.9 Medtronic Recent Developments
11.4 Terumo
11.4.1 Terumo Corporation Information
11.4.2 Terumo Business Overview
11.4.3 Terumo PTCA Dilatation Balloon Catheters Product Models, Descriptions and Specifications
11.4.4 Terumo PTCA Dilatation Balloon Catheters Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Terumo PTCA Dilatation Balloon Catheters Sales by Product in 2024
11.4.6 Terumo PTCA Dilatation Balloon Catheters Sales by Application in 2024
11.4.7 Terumo PTCA Dilatation Balloon Catheters Sales by Geographic Area in 2024
11.4.8 Terumo PTCA Dilatation Balloon Catheters SWOT Analysis
11.4.9 Terumo Recent Developments
11.5 Bluesail
11.5.1 Bluesail Corporation Information
11.5.2 Bluesail Business Overview
11.5.3 Bluesail PTCA Dilatation Balloon Catheters Product Models, Descriptions and Specifications
11.5.4 Bluesail PTCA Dilatation Balloon Catheters Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Bluesail PTCA Dilatation Balloon Catheters Sales by Product in 2024
11.5.6 Bluesail PTCA Dilatation Balloon Catheters Sales by Application in 2024
11.5.7 Bluesail PTCA Dilatation Balloon Catheters Sales by Geographic Area in 2024
11.5.8 Bluesail PTCA Dilatation Balloon Catheters SWOT Analysis
11.5.9 Bluesail Recent Developments
11.6 B. Braun
11.6.1 B. Braun Corporation Information
11.6.2 B. Braun Business Overview
11.6.3 B. Braun PTCA Dilatation Balloon Catheters Product Models, Descriptions and Specifications
11.6.4 B. Braun PTCA Dilatation Balloon Catheters Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 B. Braun Recent Developments
11.7 Acrostak
11.7.1 Acrostak Corporation Information
11.7.2 Acrostak Business Overview
11.7.3 Acrostak PTCA Dilatation Balloon Catheters Product Models, Descriptions and Specifications
11.7.4 Acrostak PTCA Dilatation Balloon Catheters Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Acrostak Recent Developments
11.8 KANEKA
11.8.1 KANEKA Corporation Information
11.8.2 KANEKA Business Overview
11.8.3 KANEKA PTCA Dilatation Balloon Catheters Product Models, Descriptions and Specifications
11.8.4 KANEKA PTCA Dilatation Balloon Catheters Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 KANEKA Recent Developments
11.9 GENOSS
11.9.1 GENOSS Corporation Information
11.9.2 GENOSS Business Overview
11.9.3 GENOSS PTCA Dilatation Balloon Catheters Product Models, Descriptions and Specifications
11.9.4 GENOSS PTCA Dilatation Balloon Catheters Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 GENOSS Recent Developments
11.10 Biotronik
11.10.1 Biotronik Corporation Information
11.10.2 Biotronik Business Overview
11.10.3 Biotronik PTCA Dilatation Balloon Catheters Product Models, Descriptions and Specifications
11.10.4 Biotronik PTCA Dilatation Balloon Catheters Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Biotronik Recent Developments
11.11 Translumina
11.11.1 Translumina Corporation Information
11.11.2 Translumina Business Overview
11.11.3 Translumina PTCA Dilatation Balloon Catheters Product Models, Descriptions and Specifications
11.11.4 Translumina PTCA Dilatation Balloon Catheters Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Translumina Recent Developments
11.12 Alvimedica
11.12.1 Alvimedica Corporation Information
11.12.2 Alvimedica Business Overview
11.12.3 Alvimedica PTCA Dilatation Balloon Catheters Product Models, Descriptions and Specifications
11.12.4 Alvimedica PTCA Dilatation Balloon Catheters Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Alvimedica Recent Developments
11.13 Cordis
11.13.1 Cordis Corporation Information
11.13.2 Cordis Business Overview
11.13.3 Cordis PTCA Dilatation Balloon Catheters Product Models, Descriptions and Specifications
11.13.4 Cordis PTCA Dilatation Balloon Catheters Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Cordis Recent Developments
11.14 Balton
11.14.1 Balton Corporation Information
11.14.2 Balton Business Overview
11.14.3 Balton PTCA Dilatation Balloon Catheters Product Models, Descriptions and Specifications
11.14.4 Balton PTCA Dilatation Balloon Catheters Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 Balton Recent Developments
11.15 Hexacath
11.15.1 Hexacath Corporation Information
11.15.2 Hexacath Business Overview
11.15.3 Hexacath PTCA Dilatation Balloon Catheters Product Models, Descriptions and Specifications
11.15.4 Hexacath PTCA Dilatation Balloon Catheters Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 Hexacath Recent Developments
11.16 InSitu Technologies
11.16.1 InSitu Technologies Corporation Information
11.16.2 InSitu Technologies Business Overview
11.16.3 InSitu Technologies PTCA Dilatation Balloon Catheters Product Models, Descriptions and Specifications
11.16.4 InSitu Technologies PTCA Dilatation Balloon Catheters Sales, Price, Revenue and Gross Margin (2020-2025)
11.16.5 InSitu Technologies Recent Developments
11.17 Teleflex
11.17.1 Teleflex Corporation Information
11.17.2 Teleflex Business Overview
11.17.3 Teleflex PTCA Dilatation Balloon Catheters Product Models, Descriptions and Specifications
11.17.4 Teleflex PTCA Dilatation Balloon Catheters Sales, Price, Revenue and Gross Margin (2020-2025)
11.17.5 Teleflex Recent Developments
11.18 MicroPort
11.18.1 MicroPort Corporation Information
11.18.2 MicroPort Business Overview
11.18.3 MicroPort PTCA Dilatation Balloon Catheters Product Models, Descriptions and Specifications
11.18.4 MicroPort PTCA Dilatation Balloon Catheters Sales, Price, Revenue and Gross Margin (2020-2025)
11.18.5 MicroPort Recent Developments
11.19 APT Medical
11.19.1 APT Medical Corporation Information
11.19.2 APT Medical Business Overview
11.19.3 APT Medical PTCA Dilatation Balloon Catheters Product Models, Descriptions and Specifications
11.19.4 APT Medical PTCA Dilatation Balloon Catheters Sales, Price, Revenue and Gross Margin (2020-2025)
11.19.5 APT Medical Recent Developments
11.20 BrosMed Medical
11.20.1 BrosMed Medical Corporation Information
11.20.2 BrosMed Medical Business Overview
11.20.3 BrosMed Medical PTCA Dilatation Balloon Catheters Product Models, Descriptions and Specifications
11.20.4 BrosMed Medical PTCA Dilatation Balloon Catheters Sales, Price, Revenue and Gross Margin (2020-2025)
11.20.5 BrosMed Medical Recent Developments
11.21 OrbusNeich Medical
11.21.1 OrbusNeich Medical Corporation Information
11.21.2 OrbusNeich Medical Business Overview
11.21.3 OrbusNeich Medical PTCA Dilatation Balloon Catheters Product Models, Descriptions and Specifications
11.21.4 OrbusNeich Medical PTCA Dilatation Balloon Catheters Sales, Price, Revenue and Gross Margin (2020-2025)
11.21.5 OrbusNeich Medical Recent Developments
11.22 Lepu Medical
11.22.1 Lepu Medical Corporation Information
11.22.2 Lepu Medical Business Overview
11.22.3 Lepu Medical PTCA Dilatation Balloon Catheters Product Models, Descriptions and Specifications
11.22.4 Lepu Medical PTCA Dilatation Balloon Catheters Sales, Price, Revenue and Gross Margin (2020-2025)
11.22.5 Lepu Medical Recent Developments
11.23 Shunmei Medical
11.23.1 Shunmei Medical Corporation Information
11.23.2 Shunmei Medical Business Overview
11.23.3 Shunmei Medical PTCA Dilatation Balloon Catheters Product Models, Descriptions and Specifications
11.23.4 Shunmei Medical PTCA Dilatation Balloon Catheters Sales, Price, Revenue and Gross Margin (2020-2025)
11.23.5 Shunmei Medical Recent Developments
11.24 Shanghai INT Medical
11.24.1 Shanghai INT Medical Corporation Information
11.24.2 Shanghai INT Medical Business Overview
11.24.3 Shanghai INT Medical PTCA Dilatation Balloon Catheters Product Models, Descriptions and Specifications
11.24.4 Shanghai INT Medical PTCA Dilatation Balloon Catheters Sales, Price, Revenue and Gross Margin (2020-2025)
11.24.5 Shanghai INT Medical Recent Developments
11.25 Sinomed
11.25.1 Sinomed Corporation Information
11.25.2 Sinomed Business Overview
11.25.3 Sinomed PTCA Dilatation Balloon Catheters Product Models, Descriptions and Specifications
11.25.4 Sinomed PTCA Dilatation Balloon Catheters Sales, Price, Revenue and Gross Margin (2020-2025)
11.25.5 Sinomed Recent Developments
11.26 Nanjing YDB Medical
11.26.1 Nanjing YDB Medical Corporation Information
11.26.2 Nanjing YDB Medical Business Overview
11.26.3 Nanjing YDB Medical PTCA Dilatation Balloon Catheters Product Models, Descriptions and Specifications
11.26.4 Nanjing YDB Medical PTCA Dilatation Balloon Catheters Sales, Price, Revenue and Gross Margin (2020-2025)
11.26.5 Nanjing YDB Medical Recent Developments
11.27 Zhejiang Barty Medical
11.27.1 Zhejiang Barty Medical Corporation Information
11.27.2 Zhejiang Barty Medical Business Overview
11.27.3 Zhejiang Barty Medical PTCA Dilatation Balloon Catheters Product Models, Descriptions and Specifications
11.27.4 Zhejiang Barty Medical PTCA Dilatation Balloon Catheters Sales, Price, Revenue and Gross Margin (2020-2025)
11.27.5 Zhejiang Barty Medical Recent Developments
11.28 Medoo Medical
11.28.1 Medoo Medical Corporation Information
11.28.2 Medoo Medical Business Overview
11.28.3 Medoo Medical PTCA Dilatation Balloon Catheters Product Models, Descriptions and Specifications
11.28.4 Medoo Medical PTCA Dilatation Balloon Catheters Sales, Price, Revenue and Gross Margin (2020-2025)
11.28.5 Medoo Medical Recent Developments
11.29 Yinyi Biotech
11.29.1 Yinyi Biotech Corporation Information
11.29.2 Yinyi Biotech Business Overview
11.29.3 Yinyi Biotech PTCA Dilatation Balloon Catheters Product Models, Descriptions and Specifications
11.29.4 Yinyi Biotech PTCA Dilatation Balloon Catheters Sales, Price, Revenue and Gross Margin (2020-2025)
11.29.5 Yinyi Biotech Recent Developments
11.30 HengYi Medical
11.30.1 HengYi Medical Corporation Information
11.30.2 HengYi Medical Business Overview
11.30.3 HengYi Medical PTCA Dilatation Balloon Catheters Product Models, Descriptions and Specifications
11.30.4 HengYi Medical PTCA Dilatation Balloon Catheters Sales, Price, Revenue and Gross Margin (2020-2025)
11.30.5 HengYi Medical Recent Developments
11.31 Demax Medical
11.31.1 Demax Medical Corporation Information
11.31.2 Demax Medical Business Overview
11.31.3 Demax Medical PTCA Dilatation Balloon Catheters Product Models, Descriptions and Specifications
11.31.4 Demax Medical PTCA Dilatation Balloon Catheters Sales, Price, Revenue and Gross Margin (2020-2025)
11.31.5 Demax Medical Recent Developments
11.32 DK Medical Technology
11.32.1 DK Medical Technology Corporation Information
11.32.2 DK Medical Technology Business Overview
11.32.3 DK Medical Technology PTCA Dilatation Balloon Catheters Product Models, Descriptions and Specifications
11.32.4 DK Medical Technology PTCA Dilatation Balloon Catheters Sales, Price, Revenue and Gross Margin (2020-2025)
11.32.5 DK Medical Technology Recent Developments
11.33 SCW Medicath
11.33.1 SCW Medicath Corporation Information
11.33.2 SCW Medicath Business Overview
11.33.3 SCW Medicath PTCA Dilatation Balloon Catheters Product Models, Descriptions and Specifications
11.33.4 SCW Medicath PTCA Dilatation Balloon Catheters Sales, Price, Revenue and Gross Margin (2020-2025)
11.33.5 SCW Medicath Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 PTCA Dilatation Balloon Catheters Industry Chain
12.2 PTCA Dilatation Balloon Catheters Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 PTCA Dilatation Balloon Catheters Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 PTCA Dilatation Balloon Catheters Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 PTCA Dilatation Balloon Catheters Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global PTCA Dilatation Balloon Catheters Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global PTCA Dilatation Balloon Catheters market was valued at US$ 1394 million in 2025 and is anticipated to reach US$ 2516 million by 2032, at a CAGR of 8.9% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 163
USD 2900.00
(Single User License)
The global PTCA Dilatation Balloon Catheters market size was US$ 1394 million in 2025 and is forecast to reach a readjusted size of US$ 2516 million by 2032 with a CAGR of 8.9% during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 139
USD 4250.00
(Single User License)
The global market for PTCA Dilatation Balloon Catheters was estimated to be worth US$ 1394 million in 2025 and is projected to reach US$ 2516 million, growing at a CAGR of 8.9% from 2026 to 2032.
Published Date: 2026-03-06
Pages: 226
USD 3950.00
(Single User License)
The global PTCA Dilatation Balloon Catheters market size was US$ 1312 million in 2024 and is forecast to a readjusted size of US$ 2329 million by 2031 with a CAGR of 8.9% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 142
USD 4250.00
(Single User License)
The global market for PTCA Dilatation Balloon Catheters was estimated to be worth US$ 1312 million in 2024 and is forecast to a readjusted size of US$ 2329 million by 2031 with a CAGR of 8.9% during the forecast period 2025-2031.
Published Date: 2025-07-24
Pages: 194
USD 3950.00
(Single User License)
The global market for PTCA Dilatation Balloon Catheters was valued at US$ 1312 million in the year 2024 and is projected to reach a revised size of US$ 2329 million by 2031, growing at a CAGR of 8.9% during the forecast period.
Published Date: 2025-07-24
Pages: 143
USD 2900.00
(Single User License)
The global market for PTCA Dilatation Balloon Catheters was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 139
USD 3950.00
(Single User License)
PTCA Dilatation Balloon Catheter is intended for balloon dilatation of a hemodynamically significant coronary artery or bypass graft stenosis in patients evidencing coronary ischemia for the purpose of improving myocardial perfusion.
Published Date: 2024-01-17
Pages: 114
USD 2900.00
(Single User License)
The global PTCA Dilatation Balloon Catheters market was valued at US$ 1394 million in 2025 and is anticipated to reach US$ 2516 million by 2032, at a CAGR of 8.9% from 2026 to 2032.
Published: 2026-04-17
Pages: 163
The global PTCA Dilatation Balloon Catheters market size was US$ 1394 million in 2025 and is forecast to reach a readjusted size of US$ 2516 million by 2032 with a CAGR of 8.9% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 139
The global market for PTCA Dilatation Balloon Catheters was estimated to be worth US$ 1394 million in 2025 and is projected to reach US$ 2516 million, growing at a CAGR of 8.9% from 2026 to 2032.
Published: 2026-03-06
Pages: 226
The global PTCA Dilatation Balloon Catheters market size was US$ 1312 million in 2024 and is forecast to a readjusted size of US$ 2329 million by 2031 with a CAGR of 8.9% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 142
The global market for PTCA Dilatation Balloon Catheters was estimated to be worth US$ 1312 million in 2024 and is forecast to a readjusted size of US$ 2329 million by 2031 with a CAGR of 8.9% during the forecast period 2025-2031.
Published: 2025-07-24
Pages: 194
The global market for PTCA Dilatation Balloon Catheters was valued at US$ 1312 million in the year 2024 and is projected to reach a revised size of US$ 2329 million by 2031, growing at a CAGR of 8.9% during the forecast period.
Published: 2025-07-24
Pages: 143
The global market for PTCA Dilatation Balloon Catheters was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 139
PTCA Dilatation Balloon Catheter is intended for balloon dilatation of a hemodynamically significant coronary artery or bypass graft stenosis in patients evidencing coronary ischemia for the purpose of improving myocardial perfusion.
Published: 2024-01-17
Pages: 114
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now